We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+6.89%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$53.9B
AUM Growth
-$1.63B
(-2.9%)
Cap. Flow
-$3.55B
Cap. Flow
% of AUM
-6.58%
Top 10 Holdings %
Top 10 Hldgs %
26.17%
Holding
1,489
New
41
Increased
394
Reduced
550
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$74.8M |
| 2 |
Sysco
SYY
|
+$54M |
| 3 |
ExxonMobil
XOM
|
+$42.4M |
| 4 |
Progressive
PGR
|
+$40.9M |
| 5 |
Mondelez International
MDLZ
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.68B |
| 2 |
Broadcom
AVGO
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Canadian Natural Resources
CNQ
|
+$77.6M |
| 5 |
Gilead Sciences
GILD
|
+$60.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.08% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 10.83% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Stellantis
STLA
$21B
| $235M | 0.44% |
16,978,909
+491,633
| +3% | +$8.36M |
|
52
Vertex Pharmaceuticals
VRTX
$133B
| $233M | 0.43% |
506,457
+4,948
| +1% | +$2.38M |
|
53
Amgen
AMGN
$226B
| $231M | 0.43% |
711,647
+8,009
| +1% | +$2.62M |
|
54
Analog Devices
ADI
$187B
| $231M | 0.43% |
999,243
+21,374
| +2% | +$4.82M |
|
55
TSMC
TSM
$2.17T
| $229M | 0.42% |
1,327,786
+9,446
| +0.7% | +$1.61M |
|
56
Oracle
ORCL
$435B
| $228M | 0.42% |
1,354,438
+79,633
| +6% | +$11.5M |
|
57
Texas Instruments
TXN
$256B
| $227M | 0.42% |
1,088,670
-198,580
| -15% | -$39.9M |
|
58
Xylem
XYL
$28.3B
| $223M | 0.41% |
1,656,369
-8,721
| -0.5% | -$1.17M |
|
59
Eaton
ETN
$173B
| $220M | 0.41% |
673,631
+18,125
| +3% | +$5.54M |
|
60
Regeneron Pharmaceuticals
REGN
$83.2B
| $219M | 0.41% |
211,207
-2,617
| -1% | -$2.91M |
|
61
Republic Services
RSG
$65.7B
| $218M | 0.41% |
1,105,327
-15,704
| -1% | -$3.16M |
|
62
Pfizer
PFE
$154B
| $215M | 0.4% |
7,398,373
+83,564
| +1% | +$2.44M |
|
63
ConocoPhillips
COP
$148B
| $212M | 0.39% |
2,028,920
-22,861
| -1% | -$2.51M |
|
64
Walmart Inc
WMT
$897B
| $210M | 0.39% |
2,640,233
-115,786
| -4% | -$8.5M |
|
65
Medtronic
MDT
$114B
| $210M | 0.39% |
2,351,765
+45,661
| +2% | +$3.84M |
|
66
Intuit
INTU
$91.5B
| $194M | 0.36% |
314,704
-16,913
| -5% | -$10.8M |
|
67
Bristol-Myers Squibb
BMY
$132B
| $194M | 0.36% |
3,782,490
-454,041
| -11% | -$21.3M |
|
68
Sempra
SRE
$55.1B
| $193M | 0.36% |
2,332,884
-71,689
| -3% | -$5.73M |
|
|
69
Progressive
PGR
$124B
| $191M | 0.35% |
762,179
+176,116
| +30% | +$40.9M |
|
|
70
Mondelez International
MDLZ
$78.5B
| $189M | 0.35% |
2,545,820
+370,603
| +17% | +$26M |
|
71
Booking.com
BKNG
$160B
| $186M | 0.35% |
1,100,450
+73,025
| +7% | +$11.2M |
|
72
Danaher
DHR
$147B
| $186M | 0.35% |
678,074
-11,217
| -2% | -$2.97M |
|
73
NextEra Energy
NEE
$177B
| $183M | 0.34% |
2,158,008
-9,269
| -0.4% | -$723K |
|
74
Elevance Health
ELV
$86.2B
| $179M | 0.33% |
343,263
-923
| -0.3% | -$493K |
|
75
Monolithic Power Systems
MPWR
$67.9B
| $174M | 0.32% |
190,443
-704
| -0.4% | -$608K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2024 Portfolio in Review
As of Q3 2024, DekaBank Deutsche Girozentrale held 1,489 positions worth $53.9B, down 2.9% from $55.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
DekaBank Deutsche Girozentrale withdrew a net $3.55B in Q3 2024, closing 60 positions and reducing 550 holdings. Its most notable exit was Labcorp, an estimated $36.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.
Against the trend, DekaBank Deutsche Girozentrale opened a new position in SolarEdge worth $1.5M.
- DekaBank Deutsche Girozentrale's largest Q3 2024 buy was SolarEdge: 66,000 shares worth $1.5M.
- DekaBank Deutsche Girozentrale added most to CVS Health in Q3 2024, an estimated $74.8M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $1.68B.
- DekaBank Deutsche Girozentrale fully exited Labcorp in Q3 2024, selling an estimated $36.3M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 26% of its $53.9B portfolio in Q3 2024.
- DekaBank Deutsche Girozentrale opened 41 new positions and closed 60 in Q3 2024.
- DekaBank Deutsche Girozentrale's portfolio value fell 2.9% quarter-over-quarter to $53.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2024, filed 24 Oct 2024.